Amy Gibson
Cited by
Cited by
Exposure to opioid maintenance treatment reduces long‐term mortality
A Gibson, L Degenhardt, RP Mattick, R Ali, J White, S O'Brien
Addiction 103 (3), 462-468, 2008
The impact of opioid substitution therapy on mortality post‐release from prison: retrospective data linkage study
L Degenhardt, S Larney, J Kimber, N Gisev, M Farrell, T Dobbins, ...
Addiction 109 (8), 1306-1317, 2014
A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial
AE Gibson, CM Doran, JR Bell, A Ryan, N Lintzeris
Medical Journal of Australia 179 (1), 38-42, 2003
The increasing mortality burden of liver disease among opioid‐dependent people: cohort study
A Gibson, D Randall, L Degenhardt
Addiction 106 (12), 2186-2192, 2011
Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study
S Larney, N Gisev, M Farrell, T Dobbins, L Burns, A Gibson, J Kimber, ...
BMJ open 4 (4), e004666, 2014
A pilot study of buprenorphine—naloxone combination tablet (Suboxone«) in treatment of opioid dependence
J Bell, G Byron, A Gibson, A Morris
Drug and Alcohol Review 23 (3), 311-317, 2004
A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
L Burns, N Gisev, S Larney, T Dobbins, A Gibson, J Kimber, B Larance, ...
Addiction 110 (4), 646-655, 2015
Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records
AE Gibson, LJ Degenhardt
Drug and alcohol review 26 (4), 405-410, 2007
Opioid overdose deaths can occur in patients with naltrexone implants
AE Gibson, LJ Degenhardt, WD Hall
Medical Journal of Australia 187 (1), 56-57, 2007
Mortality among people who use illicit drugs: A toolkit for classifying major causes of death
D Randall, A Roxburgh, A Gibson, L Degenhardt
Compliance with telephone triage advice among adults aged 45 years and older: an Australian data linkage study
DT Tran, A Gibson, D Randall, A Havard, M Byrne, M Robinson, A Lawler, ...
BMC health services research 17, 1-13, 2017
Global and Australian heroin markets
A Gibson, L Degenhardt, L Topp, C Day, W Hall, P Dietze, R McKetin
Sydney, National Drug and Alcohol Research Centre, University of New South Wales, 2003
The contributions of viral hepatitis and alcohol to liver-related deaths in opioid-dependent people
S Larney, D Randall, A Gibson, L Degenhardt
Drug and alcohol dependence 131 (3), 252-257, 2013
Emergency department attendance after telephone triage: a population‐based data linkage study
A Gibson, D Randall, DT Tran, M Byrne, A Lawler, A Havard, M Robinson, ...
Health services research 53 (2), 1137-1162, 2018
Depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy
L Degenhardt, A Gibson, RP Mattick, W Hall
Drug and alcohol review 27 (1), 1-3, 2008
Recent trends in heroin supply to markets in Australia, the United States and Western Europe
A Gibson, L Degenhardt, C Day, R McKetin
International Journal of Drug Policy 16 (5), 293-299, 2005
Follow-up difficulty: correlates and relationship with outcome in heroin dependence treatment in the NEPOD study
E Digiusto, M Panjari, A Gibson, F Rea, NEPOD Research Group
Addictive behaviors 31 (7), 1201-1210, 2006
Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous andá…
N Gisev, A Gibson, S Larney, J Kimber, M Williams, A Clifford, M Doyle, ...
BMC Public Health 14, 1-16, 2014
A cost‐effectiveness analysis of buprenorphine‐assisted heroin withdrawal
CM Doran, M Shanahan, J Bell, A Gibson
Drug and Alcohol Review 23 (2), 171-175, 2004
Mortality related to naltrexone in the treatment of opioid dependence: a comparative analysis
A Gibson, L Degenhardt
National Drug and Alcohol Research Centre, University of New South Wales, 2005
The system can't perform the operation now. Try again later.
Articles 1–20